Estimate Rate of the Women Who Have Gestational Diabetes (ERD2-DIGERD)

July 26, 2019 updated by: Centre Hospitalier René Dubos

Retrospective Study to Estimate Screening of the Type 2 Diabetes of Women Who Had Childbirth in the Hospital Center Rene Dubos and Having Gestational Diabetes

Retrospective study to estimate screening of the type 2 diabetes of women who had childbirth in the Hospital center Rene Dubos and having gestational diabetes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

It is recognized that pregnant women who had gestational diabetes (DG) multiplied by 7 subsequent risk of developing type 2 diabetes and this during 25 years. There is at present no formal recommendation of the High Authority for Health (HAS) as an organization of a long term screening for those women. However the recommendations of CNGOF (French Council of Gynaecologists and Obstetricians) and SFD (French society of diabetes) recommend screening for type 2 diabetes after a gestational diabetes in the postnatal consultation. But today how many women views due to a gestational diabetes have realized their screening? It is likely that the rate of occurrence of type 2 diabetes after gestational diabetes is underestimated today. Otherwise it is possible that the occurrence of type 2 diabetes is associated with some risk factors such as high BMI, insulin therapy during pregnancy. Another interrogation is the role of the doctor to reduce the number of women who do not realize their screening at 3 months postpartum. Better awareness of the importance of long term monitoring would reduce the proportion of women who do not realize their screening.

Study Type

Observational

Enrollment (Actual)

384

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
    • Val d'Oise
      • Pontoise, Val d'Oise, France, 95303
        • Rene Dubos Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women who had childbirth in the Hospital center Rene Dubos and having gestational diabetes.

Description

Inclusion Criteria:

  • Participants aged over 18 years
  • Participants who deliver between 01/01/2013 and 30/06/2015
  • Participants who have had a gestational diabetes
  • Participants who have been informed and have returned the questionary

Exclusion Criteria:

  • Participants who do not wishing to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
gestational diabetes women
Women who had childbirth in the Hospital center Rene Dubos and who had gestational diabetes.
Other: gestational diabetes women
No intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycemia realized after childbirth
Time Frame: 3 months
The investigators want to know the number of women who realized a Glycemia analysis.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of women who have pursued the dietary and hygiene rules
Time Frame: 3 months
Information about dietary and hygiene rules are collected on a questionnaire.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier René Dubos

Investigators

  • Principal Investigator: Catherine CAMPINOS, PH, Rene Dubos Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2015

Primary Completion (Actual)

January 1, 2017

Study Completion (Actual)

January 1, 2017

Study Registration Dates

First Submitted

July 29, 2016

First Submitted That Met QC Criteria

August 1, 2016

First Posted (Estimate)

August 2, 2016

Study Record Updates

Last Update Posted (Actual)

July 29, 2019

Last Update Submitted That Met QC Criteria

July 26, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHRD1114

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes, Gestational

Clinical Trials on gestational diabetes women

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe